Is Heron Therapeutics Inc (NASDAQ:HRTX) A Better Buy Than Others After A 156.16% Rise In This Year?
In last trading session, Heron Therapeutics Inc (NASDAQ:HRTX) saw 1.65 million shares changing hands with its beta currently measuring 1.80. Company’s recent per share price